Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade.

ABSTRACT:

SUBMITTER: Huang Z 

PROVIDER: S-EPMC11796223 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature